HPV Vaccine in the United StatesConclusion13or more doses of the HPV vaccine compared to children living in non-metropolitan areas (30.0%).The figure below shows differences in HPV vaccine coverage by age, gender, and race. Girls were more likely to be vaccinated than boys. HPV vaccination rates were also lower among Hispanics compared to whites. In the U.S., the HPV vaccine was developed and first introduced in both the U.S. and Europe in 2006.The target age for the cervical cancer vaccine, according to the Ministry of Health, Labor and Welfare, is “girls in the sixth grade through the first grade of high school,” but in the U.S., the vaccine is recommended for boys and girls aged 9to 12. 38.6% of children aged 9 to 17 had received at leastone dose of human papillomavirus (HPV) vaccine in 2022had received at least one dose of the HPV vaccine.Children with private health insurance (41.5%) were themost likely to have received one or more doses of the HPVvaccine, compared to children with Medicaid (37.0%), othergovernment insurance (30.2%), and no insurance (20.7%).The percentage of children who received one or moredoses of HPV vaccination was higher among children withdisabilities.Children living in central metropolitan areas (39.4%),surrounding urban areas (41.1%), and medium and smallurban areas (39.4%) were more likely to have received one As shown above, HPV vaccination rates vary from country to country. Still, many countries are more advanced than Japan, and I hope this helps you understand the HPV vaccine and the background of why the Japanese government is trying to increase the vaccination rate in Japan.
元のページ ../index.html#14